NVAX Financial Facts

Basic and diluted net loss per share: -0.1
General and administrative: 5.84M
See Full Income Statement

Accrued expenses and other current liabilities: 15.59M
Treasury stock, 455,430 shares, cost basis: -2.45M
See Full Balance Sheet

Novavax, Inc. (NVAX) Earnings

  |   Expand Research on NVAX
Next EPS Date 8/6/15 *Est. EPS Growth Rate -42.9% *Last Qtr.
Average EPS % Beat Rate -20.5% Revenue Growth Rate +32.0% *Last Qtr.
Average % Move 1-Wk after EPS +1.0% Normal Earnings Time After Close
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
11/7/13 Q313 N/A-$0.06 N/A N/A$4.56M N/A N/A N/A
2/26/15 Q414 -$0.13-$0.08 -$0.05N/A$9.6M N/A Details
5/7/15 Q115 -$0.10-$0.11 +$0.01$9.9M$9.7M N/A Details
3/10/14 Q413 -$0.07-$0.08 +$0.01$8.75M$6.22M N/A Details
11/5/14 Q314 -$0.08-$0.07 -$0.01$8.2M$9.2M N/A Details
8/6/14 Q214 -$0.08-$0.07 -$0.01$8.26M$8.74M N/A Details
5/7/14 Q114 -$0.07-$0.07 $0.00$7.5M$3.8M N/A Details
8/8/13 Q213 -$0.08-$0.06 -$0.02$3.52M$4.45M N/A Details